Direct in vivo monitoring of dopamine released from two striatal compartments in the rat.

Microvoltammetric electrodes were used to monitor dopamine released in the caudate nucleus of the rat after electrical stimulation of the medial forebrain bundle. The time resolution of the technique is sufficient to determine in vivo concentration changes on a time scale of seconds. Direct evidence identifying the substance released as dopamine was obtained both voltammetrically and pharmacologically. Administration of alpha-methyl-p-tyrosine terminates the release of dopamine, although tissue stores of dopamine are still present. Thus there appears to be a compartment for dopamine storage that is not available for immediate release. This compartment appears to be mobilized by amfonelic acid, since administration of this agent after alpha-methyl-p-tyrosine returns the concentration of dopamine released by electrical stimulation to 75 percent of the original amount.

[1]  P. A. Shore,et al.  On a prime role for newly synthesized dopamine in striatal function. , 1975, European journal of pharmacology.

[2]  R. Wightman,et al.  Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium. , 1982, The Journal of pharmacology and experimental therapeutics.

[3]  S. Snyder,et al.  Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of Action , 1969, Science.

[4]  R. M. Wightman,et al.  Pulse voltammetry with microvoltammetric electrodes , 1981 .

[5]  R. Wightman,et al.  Monitoring of transmitter metabolites by voltammetry in cerebrospinal fluid following neural pathway stimulation , 1976, Nature.

[6]  Michel Jouvet,et al.  In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? , 1980, Nature.

[7]  R. Wightman,et al.  In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate , 1982, Brain Research.

[8]  Andrew G. Ewing,et al.  Diffusion processes measured at microvoltammetric electrodes in brain tissue , 1983 .

[9]  P. A. Shore,et al.  Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. , 1982, European journal of pharmacology.

[10]  M. Besson,et al.  Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Glowinski,et al.  DYNAMIC CHARACTERISTICS OF THE ‘FUNCTIONAL COMPARTMENT’ OF DOPAMINE IN DOPAMINERGIC TERMINALS OF THE RAT STRIATUM , 1971, Journal of neurochemistry.

[12]  P. A. Shore.  Actions of amfonelic acid and other non‐amphetamine stimulants on the dopamine neuron * , 1976, The Journal of pharmacy and pharmacology.

[13]  R. Adams,et al.  Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry , 1979, Brain Research.

[14]  R. Adams,et al.  Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release. , 1978, Life sciences.

[15]  A. Cho,et al.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. , 1979, The Journal of pharmacology and experimental therapeutics.

[16]  M. Aceto,et al.  Pharmacologic properties and mechanism of action of amfonelic acid. , 1970, European journal of pharmacology.